Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vivek Viswanathan, Rajesh Pharande, Anilkumar Bannalikar, Pushpa Gupta, Umesh Gupta & Alka Mukne. (2019) Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies. Drug Development and Industrial Pharmacy 45:1, pages 11-20.
Read now
Read now
Fakhar ud Din, Sehrish Saleem, Fatima Aleem, Rida Ahmed, Noor ul Huda, Sohail Ahmed, Nadra Khaleeq, Kifayat Ullah Shah, Izhar Ullah, Alam Zeb & Waqar Aman. (2018) Advanced colloidal technologies for the enhanced bioavailability of drugs. Cogent Medicine 5:1.
Read now
Read now
Articles from other publishers (28)
Aditi Negi, Shubham Nimbkar & Jeyan Arthur Moses. (2023) Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches. Pharmaceutics 15:12, pages 2706.
Crossref
Crossref
Sabrina Magramane, Kristina Vlahović, Péter Gordon, Nikolett Kállai-Szabó, Romána Zelkó, István Antal & Dóra Farkas. (2023) Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. Pharmaceuticals 16:12, pages 1658.
Crossref
Crossref
Xinyuan Xi, Fan Lei, Keliang Gao, Jingjing Li, Rihe Liu, Adam R. Karpf & Tatiana K. Bronich. (2023) Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer. Journal of Controlled Release 360, pages 872-887.
Crossref
Crossref
Hend I. Shahin & Lipika Chablani. (2023) A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications. Journal of Drug Delivery Science and Technology 84, pages 104553.
Crossref
Crossref
Sona Gandhi & Indrajit Roy. (2023) Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer. Pharmaceutics 15:5, pages 1457.
Crossref
Crossref
Ching-Yee Loo, Wing-Hin Lee & Qi Tony Zhou. (2023) Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections. Pharmaceutical Research 40:5, pages 1015-1036.
Crossref
Crossref
Ali Al-Jipouri, Samah Hamed Almurisi, Khater Al-Japairai, Latifah Munirah Bakar & Abd Almonem Doolaanea. (2023) Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery. Polymers 15:2, pages 318.
Crossref
Crossref
Chetna Gupta, Aadya Jaipuria & Nikesh Gupta. (2022) Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments. Pharmaceutics 15:1, pages 139.
Crossref
Crossref
Nidhi Nainwal. (2022) Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities. Pulmonary Pharmacology & Therapeutics 77, pages 102170.
Crossref
Crossref
Jigar D. Vanza, Dhwani M. Shah, Rashmin B. Patel & Mrunali R. Patel. (2022) Afatinib liposomal dry powder inhaler: Targeted pulmonary delivery of EGFR inhibitor for the management of lung cancer. Journal of Drug Delivery Science and Technology 74, pages 103506.
Crossref
Crossref
Gülsel Yurtdaş-Kırımlıoğlu, Kadri Güleç, Şennur Görgülü & Hülya Tuba Kıyan. (2022) Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay. Microvascular Research 139, pages 104251.
Crossref
Crossref
Gülsel Yurtdaş-Kırımlıoğlu, Şennur Görgülü, Kadri Güleç & Hülya Tuba Kıyan. (2022) Nanoarchitectonics of PLGA based polymeric nanoparticles with oseltamivir phosphate for lung cancer therapy: In vitro-in vivo evaluation. Journal of Drug Delivery Science and Technology 67, pages 102996.
Crossref
Crossref
Salma N. Tammam, Sara El Safy, Shahenda Ramadan, Sita Arjune, Eva Krakor & Sanjay Mathur. (2021) Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. Journal of Controlled Release 337, pages 258-284.
Crossref
Crossref
Michelle Alvares Sarcinelli, Thalita Martins da Silva, Andressa Daniele Artico Silva, Beatriz Ferreira de Carvalho Patricio, Flávia Costa Mendes de Paiva, Raissa Santos de Lima, Manuela Leal da Silva & Helvécio Vinícius Antunes Rocha. (2021) The pulmonary route as a way to drug repositioning in COVID-19 therapy. Journal of Drug Delivery Science and Technology 63, pages 102430.
Crossref
Crossref
S.C. Das, P. Khadka, R. Shah, S. McGill & H.D.C. Smyth. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
319
354
.
Birendra Chaurasiya & You-Yang Zhao. (2020) Dry Powder for Pulmonary Delivery: A Comprehensive Review. Pharmaceutics 13:1, pages 31.
Crossref
Crossref
Shahir Aziz, Regina Scherlieβ & Hartwig Steckel. (2020) Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia. Pharmaceutics 12:12, pages 1154.
Crossref
Crossref
Harshal Sahastrabudhe, Prathmesh Kenjale & Varsha Pokharkar. (2020) Development of Sustained Release Oseltamivir Phosphate Dry Powder Inhaler: In-Vitro Characterization and In-Vivo Toxicological Studies. Current Drug Delivery 17:8, pages 703-710.
Crossref
Crossref
Yue Xing, Peng Lu, Zhifeng Xue, Chunxia Liang, Bing Zhang, Dereje Kebebe, Hongfei Liu & Zhidong Liu. (2020) Nano-Strategies for Improving the Bioavailability of Inhaled Pharmaceutical Formulations. Mini-Reviews in Medicinal Chemistry 20:13, pages 1258-1271.
Crossref
Crossref
Bushra Nabi, Saleha Rehman, Sumit Aggarwal, Sanjula Baboota & Javed Ali. (2020) Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention. Drug Delivery and Translational Research 10:4, pages 1111-1121.
Crossref
Crossref
Bhagirath Limbani, Smritilekha Bera & Dhananjoy Mondal. (2020) Synthetic Advancement of Neuraminidase Inhibitor “Tamiflu”. ChemistrySelect 5:20, pages 6083-6122.
Crossref
Crossref
Piyush P. Mehta, Debjit Ghoshal, Atmaram P. Pawar, Shivajirao S. Kadam & Vividha S. Dhapte-Pawar. (2020) Recent advances in inhalable liposomes for treatment of pulmonary diseases: Concept to clinical stance. Journal of Drug Delivery Science and Technology 56, pages 101509.
Crossref
Crossref
Isra Khatib, Patricia Tang, Juanfang Ruan, David Cipolla, Francis Dayton, James D. Blanchard & Hak-Kim Chan. (2020) Formation of ciprofloxacin nanocrystals within liposomes by spray drying for controlled release via inhalation. International Journal of Pharmaceutics 578, pages 119045.
Crossref
Crossref
Fereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, Yousef Fatahi, Niayesh Shakeri, Rassoul Dinarvand, Timo L.M. Ten Hagen & Azadeh Haeri. (2020) Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation. Advances in Colloid and Interface Science 277, pages 102121.
Crossref
Crossref
Ye Bi, Bingcong Lv, Lianlian Li, Robert J. Lee, Jing Xie, Zhidong Qiu & Lesheng Teng. (2020) A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine. Molecules 25:2, pages 338.
Crossref
Crossref
Enas Elmowafy & Mahmoud E. Soliman. (2019) Losartan-chitosan/dextran sulfate microplex as a carrier to lung therapeutics: Dry powder inhalation, aerodynamic profile and pulmonary tolerability. International Journal of Biological Macromolecules 136, pages 220-229.
Crossref
Crossref
Isra Khatib, Dipesh Khanal, Juanfang Ruan, David Cipolla, Francis Dayton, James D. Blanchard & Hak-Kim Chan. (2019) Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation. International Journal of Pharmaceutics 566, pages 641-651.
Crossref
Crossref
Amira Hamed, Rihab Osman, Khuloud T. Al-Jamal, Samar Mansour Holayel & Ahmed-Shawky Geneidi. (2019) Enhanced antitubercular activity, alveolar deposition and macrophages uptake of mannosylated stable nanoliposomes. Journal of Drug Delivery Science and Technology 51, pages 513-523.
Crossref
Crossref